The Quantitative Systems Pharmacology (QSP) Summit is a free conference dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its eighth year, the QSP Summit is a one-day event featuring talks from key industry and academic researchers, a poster session, and networking time with peers.
エリア： Le Meridien Boston Cambridge, 20 Sidney Street, Cambridge, MA 02139
講演者
- Kerry Culm, Chief Development Officer at ModeX Therapeutics
- Karthik Venkatakrishnan, Vice President and Global Head of Quantitative Pharmacology, at EMD Serono
- Lioudmila Tchistiakova, Venture Partner at Third Rock Ventures
- Josh Apgar, VP of QSP Software and Products at Certara
- Allison Claas, Sr Principal Scientist at Novartis
- Anna Sher, Sr Director, QSP at GSK
- Hojjat Bazzazi, Director, Quantitative Systems Pharmacology, at Moderna
Abstract Guidelines
- Key Dates
- Abstract submission deadline: 2025年3月14日 (金曜日)
- Notification of acceptance: 2025年3月21日 (金曜日)
- QSP Summit: 2025年4月10日 (木曜日)
- Abstract Guidelines
- Abstract submission is open to all undergraduate, graduate, postdoctoral, industry (biotechs and pharma), faculty, and staff in any computational biology field.
- Abstracts presented at other forums may be repurposed for this event.
- Abstracts must represent scientific research that cannot be perceived as marketing a specific company or product.
- Abstracts will be considered for either a full-length presentation (30 minutes) and/or poster presentation.
- Please limit the abstract to 250 words.
